CVS Slides After Rating Cut On Remuneration Fees Exposure
February 02, 2017 at 15:20 PM EST
Shares of CVS Health are sliding after Baird analyst Eric Coldwell downgraded the stock to Neutral, voicing concern over the company's exposure to Direct and Indirect Remuneration, or DIR, fees.
